Drain
DevicePost modified radical mastectomy with either one or two drains Intervention is use of single or double drain
NCT Number: NCT02411617
Seroma is a common complication following modified radical mastectomy(MRM). Closed drainage is used routinely to reduce incidence of seroma. Usually two drains are used in patients who underwent MRM to reduce post operative seroma. It is often associated with significant patient discomfort and prolonged fluid drainage.
The aim of this study is to evaluate effect of number of drains on seroma formation rate, postoperative pain and hospital stay during the immediate postoperative period after mastectomy for breast cancer.
Looking for future studies?
Notify MeFemale
Interventional
Not applicable
Modified Radical mastectomy is commonly performed procedure for carcinoma breast. After surgery two drains are placed, one in axilla and one beneath the flap. The use of two drains is associated with significant post operative discomfort and pain. On the other hand two drains have not been proven to decrease post operative seroma formation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Post modified radical mastectomy with either one or two drains Intervention is use of single or double drain
Time frame: 30 days post surgery
fluid collection beneath the flap sufficient to cause patient discomfort and pain
Time frame: 30 days after surgery
Time frame: 30 days after surgery
as described by center of disease control (CDC) criteria
Time frame: 30 days after surgery
measured on visual analogue scale (1 to 10) in first 24 hours after surgery.
Time frame: 30 days after surgery
blood collection under the flap
Time frame: 30 days after surgery
flap discoloration due to compromised blood supply of flap
Memon Medical Institute
Other
Single vs. Double Drain in Modified Radical Mastectomy: A Randomized Control Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT05754658
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07040514
Breast Cancer, Breast Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNCT06604858
Breast Cancer, Breast Diseases
A Coruña, Spain
View Trial Details